Stay updated with breaking news from Cinney Zhang. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The US-dominated biotech landscape is evolving as aging populations and lifestyle-related diseases become global health issues, impacting Asia, as much as the rest...
The fund has assets of £379million, and managed for the past decade by Linden Thomson who has 19 years' experience of investing in healthcare stocks.
The fund has assets of £379million, and managed for the past decade by Linden Thomson who has 19 years' experience of investing in healthcare stocks.
The pandemic has exacted a huge human and financial toll, but it has also transformed scientific research in ways that will deliver huge benefits for healthcare. Matthew Partridge reports.
Merck Setback Limits Study of Covid Pill to Milder Disease Bloomberg 5 hrs ago Riley Griffin and Cynthia Koons (Bloomberg) -- Merck & Co. halted development of two experimental drugs for patients hospitalized with Covid-19 and began a final trial of one of them, its highly anticipated antiviral pill, for people with milder disease after getting mixed results about the medicine’s benefits. Popular Searches The pill known as molnupiravir reduced virus levels in patients during a mid-stage study but didn’t show a meaningful benefit in preventing hospitalizations and deaths,...